drugset / Trial / NCT00494767
Investigation Of Weight Loss And Body Composition Changes After Dosing With Either Placebo Or One Of Two Active Drugs
RandomizedParallel-groupTreatment
Summary
The drugs GSK189075 and GW869682 result in increased caloric losses. This study is investigating how if taken over 8 weeks that affects weight loss, food intake and the composition of the body. The body composition (fat,water, lean mass) is determined using a new investigational MR technology.
Timeline
- Start
- 2006-09-29
- Primary completion
- 2007-06-07
- Completion
- 2007-06-07
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | GW869682 | Unknown | 1000 mg | — |
| Subject | remogliflozin etabonate | Small molecule | 250 mg | — |